Zydus Lifesciences plant inspection ends with five USFDA observations
In short
Zydus Lifesciences said USFDA inspectors finished a visit to its Moraiya plant in Ahmedabad on October 13. The inspection ran from October 5 to October 13 and ended with five observations.
The company said it will work with the USFDA to fix the issues quickly. It is not clear what the observations were or whether there will be any further action.
What the reporting says
Zydus Lifesciences said the USFDA inspection of its Moraiya manufacturing plant in Ahmedabad concluded on October 13 with five observations. The inspection ran from October 5 to October 13, and the company said it would work with the USFDA to address the observations expeditiously. The reporting does not state the nature of the observations or any regulatory action that may follow.
Why it matters
Zydus Lifesciences said the USFDA inspection of its Moraiya manufacturing plant in Ahmedabad ended on October 13 with five observations, after running from October 5 to October 13. The company said it would work with the regulator to address the observations expeditiously. The reporting does not say whether the observations are major or whether they could affect approvals, production, or sales.